These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 408896)

  • 21. [A case of chagas infection caused by an atypical strain of Trypanosoma cruzi in a newborn infant].
    de Storni P; Bakos E; Bustamante A; Vanioff JA
    Medicina (B Aires); 1984; 44(3):287-91. PubMed ID: 6443628
    [No Abstract]   [Full Text] [Related]  

  • 22. [The chemotherapy of Chagas disease].
    Stoppani AO
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ketoconazole promotes parasitological cure of mice infected with Trypanosoma cruzi.
    McCabe RE; Remington JS; Araujo FG
    Trans R Soc Trop Med Hyg; 1987; 81(4):613-5. PubMed ID: 3127963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of immunosuppression and benzonidazole on Trypanosoma cruzi parasitism during experimental acute Chagas' disease.
    Okumura M; Mester M; Iriya K; Amato Neto V; Gama-Rodrigues J
    Transplant Proc; 1994 Jun; 26(3):1587-9. PubMed ID: 8030049
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and in vitro evaluation of potential antichagasic hydroxymethylnitrofurazone (NFOH-121): a new nitrofurazone prodrug.
    Chung MC; Güido RV; Martinelli TF; Gonçalves MF; Polli MC; Botelho KC; Varanda EA; Colli W; Miranda MT; Ferreira EI
    Bioorg Med Chem; 2003 Nov; 11(22):4779-83. PubMed ID: 14556793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A new thioisonicotinic acid amide active against Trypanosoma cruzi in experimentally infected NMRI mice].
    Raether W; Schorr M; Seidenath H
    Z Tropenmed Parasitol; 1972 Sep; 23(3):227-40. PubMed ID: 4628842
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of sodium cyanate on Trypanosoma cruzi in culture.
    Nadler JP; Tanowitz HB; Raventos C; Nagel RL; Wittner M
    Trans R Soc Trop Med Hyg; 1981; 75(5):710-2. PubMed ID: 6800074
    [No Abstract]   [Full Text] [Related]  

  • 28. Trypanosoma cruzi: establishment of permeable cells for RNA processing analysis with drugs.
    Ambrósio DL; Barbosa CF; Vianna VF; Cicarelli RM
    Mem Inst Oswaldo Cruz; 2004 Oct; 99(6):617-20. PubMed ID: 15558173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The activity against Trypanosoma cruzi and cutaneous leishmaniasis, and toxicity, of moxipraquine (349C59).
    Beveridge E; Caldwell IC; Latter VS; Neal RA; Udall V; Waldron MM
    Trans R Soc Trop Med Hyg; 1980; 74(1):43-51. PubMed ID: 6776663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chemotherapeutic studies on Trypanosoma cruzi in tissue culture].
    Mieth H; Seidenath H
    Z Tropenmed Parasitol; 1967 Apr; 18(1):53-60. PubMed ID: 5589385
    [No Abstract]   [Full Text] [Related]  

  • 31. Genetic transfer in trypanosomes. I. Syngamy in Trypanosoma cruzi.
    Amrein YU
    Exp Parasitol; 1965 Dec; 17(3):261-3. PubMed ID: 5856848
    [No Abstract]   [Full Text] [Related]  

  • 32. Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions.
    Caldas IS; Talvani A; Caldas S; Carneiro CM; de Lana M; da Matta Guedes PM; Bahia MT
    Parasitol Res; 2008 Jul; 103(2):413-21. PubMed ID: 18454349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The identification by lectins of two strain groups of Trypanosoma cruzi.
    Schottelius J
    Z Parasitenkd; 1982; 68(2):147-54. PubMed ID: 6755944
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types.
    Andrade SG; Magalhães JB; Pontes AL
    Bull World Health Organ; 1985; 63(4):721-6. PubMed ID: 3936634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic action of MK-436 (2,5-nitroimidazole) on Trypanosoma cruzi infections in mice: a parasitological, serological, histopathological, and ultrastructural study.
    Andrade SG; Silva RC; Santiago CM; Freitas LA
    Bull World Health Organ; 1987; 65(5):625-33. PubMed ID: 3123082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experimental study on the resistance of a strain of Trypanosoma cruzi to Bay 2502].
    Andrade SG; Andrade ZA; Figueira RM
    Rev Inst Med Trop Sao Paulo; 1977; 19(2):124-9. PubMed ID: 408896
    [No Abstract]   [Full Text] [Related]  

  • 37. Animal experimental investigation into the activity of nifurtimox against Trypanosoma cruzi.
    Haberkorn A; Gönnert R
    Arzneimittelforschung; 1972 Sep; 22(9):1570-82. PubMed ID: 4630483
    [No Abstract]   [Full Text] [Related]  

  • 38. [Reaction of the Trypanosoma cruzi strain to the experimental therapeutical response to Bay 2502 (results of long term treatment)].
    Andrade SG; Figueira RM; Carvalho ML; Gorini DF
    Rev Inst Med Trop Sao Paulo; 1975; 17(6):380-9. PubMed ID: 815983
    [No Abstract]   [Full Text] [Related]  

  • 39. [Etiological treatment of Chagas' disease].
    Rassi A
    Arq Bras Cardiol; 1982 Apr; 38(4):277-81. PubMed ID: 6820273
    [No Abstract]   [Full Text] [Related]  

  • 40. Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease.
    Neres J; Bryce RA; Douglas KT
    Drug Discov Today; 2008 Feb; 13(3-4):110-7. PubMed ID: 18275908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.